What Researchers Did
The authors reviewed published medical articles from 1980 to 2016 to describe what is known about how common critical limb ischemia is, what causes it, how it is diagnosed, and how it is treated.
What They Found
This systematic review of English-language articles found that critical limb ischemia is the end stage of peripheral arterial disease, and that revascularization (restoring blood flow) is the cornerstone of therapy to prevent limb amputation. Peripheral arterial disease is most commonly caused by atherosclerosis, so the condition is heavily associated with smoking and diabetes. Both open vascular surgery and endovascular therapy play a key role in treatment. However, few scientific data are available to show which revascularization strategy is best, which has led to a lot of variability and equipoise in how the condition is treated. Medical therapy helps optimize other cardiovascular risk factors but has only a limited role in improving limb outcomes when revascularization is not possible. The abstract describes the condition as highly morbid, with a high risk of limb loss and death.
What This Means for Canadian Patients
The abstract does not mention hyperbaric oxygen therapy, so it does not address HBOT. It covers only critical limb ischemia in general: surgery and endovascular treatment are central, and the best approach between them is not settled. Patients with this condition should talk with a vascular specialist about their treatment options.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The abstract states that few scientific data exist to identify the best revascularization strategy, and it reports no sample size or pooled statistics, so it gives no numbers to compare treatments.